Similar articles

• Comparison of two pancreatic enzyme products for exocrine insufficiency in patients with cystic fibrosis.

  Taylor CJ, Thieroff-Ekerdt R, Shiff S, Magnus L, Fleming R, Gommoll C. Taylor CJ, et al. J Cyst Fibros. 2016 Sep;15(5):675-80. doi: 10.1016/j.jcf.2016.02.010. Epub 2016 Mar 21. J Cyst Fibros. 2016. PMID: 27013382 Clinical Trial.
• Detection and follow up of exocrine pancreatic insufficiency in cystic fibrosis: a review.

  Leus J, Van Biervliet S, Robberecht E. Leus J, et al. Eur J Pediatr. 2000 Aug;159(8):563-8. doi: 10.1007/s004310000507. Eur J Pediatr. 2000. PMID: 10968231 Review.
• Pancreatic enzyme replacement therapy for people with cystic fibrosis (Review).

  Somaraju UR, Solis-Moya A. Somaraju UR, et al. Paediatr Respir Rev. 2015 Mar;16(2):108-9. doi: 10.1016/j.prrv.2014.11.001. Epub 2014 Nov 15. Paediatr Respir Rev. 2015. PMID: 25497671 Review. No abstract available.
• [Diagnosis and therapy of chronic pancreatitis].

  Mahlke R, Lübbers H, Lankisch PG. Mahlke R, et al. Internist (Berl). 2005 Feb;46(2):145-56. doi: 10.1007/s00108-004-1307-3. Internist (Berl). 2005. PMID: 15633047 Review. German.
• Pancreatic enzyme therapy and gastrointestinal symptoms in patients with cystic fibrosis.

  Walkowiak J, Lisowska A. Walkowiak J, et al. J Pediatr. 2005 Dec;147(6):870-1. doi: 10.1016/j.jpeds.2005.09.016. J Pediatr. 2005. PMID: 16356455 No abstract available.